1 Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet Lond Engl. 2014;383:1749–61.
doi:10.1016/S0140-6736(14)60121–5.
2 Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014;12:145.
doi:10.1186/s12916-014-0145-y.
3 Goosens M. Nichtalkoholische Fettlebererkrankung: Schluss mit der Banalisierung! Swiss Med Forum. 2018;18(1–2):10–12.
4 Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet Lond Engl. 2013;381:468–75.
doi:10.1016/S0140-6736(12)61425-1.
5 Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64:830–41.
doi:10.1136/gutjnl-2014-306842.
6 Hytiroglou P, Snover DC, Alves V, Balabaud C, Bhathal PS, Bioulac-Sage P, et al. Beyond “cirrhosis”: a proposal from the International Liver Pathology Study Group. Am J Clin Pathol. 2012;137:5–9.
doi:10.1309/AJCP2T2OHTAPBTMP.
7 Gustot T, Moreau R. Acute-on-Chronic Liver Failure vs. Traditional Acute Decompensation of Cirrhosis. J Hepatol 2018.
doi:10.1016/j.jhep.2018.08.024.
8 EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406–60.
doi:10.1016/j.jhep.2018.03.024.
9 European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397–417.
doi:10.1016/j.jhep.2010.05.004.
10 Runyon BA, AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatol Baltim Md. 2013;57:1651–3.
doi:10.1002/hep.26359.
11 Marcellin P, Kutala BK. Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int Off J Int Assoc Study Liver. 2018;38 Suppl 1:2–6.
doi:10.1111/liv.13682.
12 EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–402.
doi:10.1016/j.jhep.2015.11.004.
13 Modi AA, Feld JJ, Park Y, Kleiner DE, Everhart JE, Liang TJ, et al. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology. 2010;51:201–9.
doi:10.1002/hep.23279.
14 Alferink LJM, Fittipaldi J, Kiefte-de Jong JC, Taimr P, Hansen BE, Metselaar HJ, et al. Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study. J Hepatol. 2017;67:339–48.
doi:10.1016/j.jhep.2017.03.013.
15 European Association for the Study of the Liver. Electronic address: easloffice[at]easloffice.eu, European Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2018. J Hepatol. 2018;69:461–511.
doi:10.1016/j.jhep.2018.03.026.
16 Singh S, Facciorusso A, Loomba R, Falck-Ytter YT. Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 2018;16:27–38.e4.
doi:10.1016/j.cgh.2017.04.038.
17 Lens S, Alvarado-Tapias E, Mariño Z, Londoño M-C, LLop E, Martinez J, et al. Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis. Gastroenterology 2017;153:1273–83.e1.
doi:10.1053/j.gastro.2017.07.016.
18 Hernández-Gea V, Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, et al. Preemptive-TIPS improves outcome in high-risk variceal bleeding: An observational study. Hepatol Baltim Md 2018.
doi:10.1002/hep.30182.
19 Thabut D, Pauwels A, Carbonell N, Remy AJ, Nahon P, Causse X, et al. Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results. J Hepatol 2017.
doi:10.1016/j.jhep.2017.09.002.
20 Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet Lond Engl. 2018;391:2417–29.
doi:10.1016/S0140-6736(18)30840-7.